Pregnancy-associated plasma protein A (PAPP-A), a novel biomarker linked to reduced CFR in HFpEF and predictive of cardiovascular events in acute coronary syndrome (ACS), underscores the role of subclinical atherosclerosis in the pathophysiology of CMD and HFpEF [40]. This evidence concerns the gene PAPPA and acute coronary syndrome.